A global biotech company specialising in Immunology and Inflammation was approaching a criti...
A global biotech company specialising in Immunology and Inflammation was approaching a criti...
The U.S. compounding landscape changed substantially when the United States Pharmacopeia (US...
As 2025 draws to a close, it is evident that the industry has not pursued radical transforma...
The hidden leakage across R&D, regulatory and launchRecent headlines are leaving little ...
Regeneron Pharmaceuticals has agreed to acquire almost all of 23andMe’s business lines, whic...
We delivered market insights and a VP Finance shortlist, supporting a Swiss oncology biotech...
Rapid contractor placements in Epidemiology helped our client meet deadlines and avoid delay...
We enabled a rapidly expanding biotech in Woburn, Massachusetts to hit a 66% growth target b...